The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - ARIAD; AstraZeneca; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Ignyta (Inst); Pfizer (Inst)
Efficacy and safety of alectinib in ALK+ non-small-cell lung cancer (NSCLC): Pooled data from two pivotal phase II studies (NP28673 and NP28761).
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
 
Sai-Hong Ignatius Ou
No Relationships to Disclose
 
Luigi De Petris
Honoraria - AstraZeneca; Quiagen; Roche
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
 
Shirish M. Gadgeel
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Novartis; Pfizer
Speakers' Bureau - Genentech/Roche
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
 
Leena Gandhi
Honoraria - Merck
Consulting or Advisory Role - Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb
 
Dong-Wan Kim
No Relationships to Disclose
 
Fabrice Barlesi
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Anne-Marie C. Dingemans
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
Speakers' Bureau - Roche
 
Lucio Crino
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Hervé Lena
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Boehringer Ingelheim; Lilly; Roche/Genentech
 
Sanjay Popat
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Jin Seok Ahn
Honoraria - AstraZeneca; Janssen; Lilly; Menarini; Roche
Consulting or Advisory Role - Boehringer Ingelheim
 
Eric Dansin
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche (Inst)
 
Sophie Golding
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Walter Bordogna
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Bogdana Balas
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Peter N. Morcos
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Ali Hassan Zeaiter
Employment - Roche
Leadership - Roche
Stock and Other Ownership Interests - Roche
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech